National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN ORP Recent News
NCCN ORP Scientific Publications
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN ORP for Industry
NCCN Health Information Technology Licensees

NCCN Research & Business Resources


Duke Cancer Institute
Durham, North Carolina
888.275.3853 (888.ASK.DUKE)
www.cancer.duke.edu

Adult Oncology Services

Introduction

Since its inception in 1972 as one of the nation's first comprehensive cancer centers, the Duke Cancer Institute has been at the forefront of efforts to understand, prevent, diagnose, and treat cancer through patient care, clinical research, laboratory investigation, and education. Every activity the Cancer Center undertakes-from basic research to clinical trials to educational programs-is aimed at improving the care of cancer patients.

The Duke Cancer Institute is a matrix center-one that draws upon the depth of basic scientific research and clinical expertise of the Duke University Medical Center . The formal structure consists of:

· 11 established research programs (divided into basic, translational, and clinical research programs)

· 17 Shared Resources

· 21 member Executive Committee

· Protocol Review and Monitoring System

The "comprehensive" status recognizes the center for its excellence in research and for other contributions in the areas of clinical trials, prevention and control efforts, information and educational offerings, and outreach and service activities. Duke Cancer Institute's more than 350 physicians and scientists research all aspects of cancer biology and treatment.

General Information

General Information

Call 888.275.3853 (888.ASK.DUKE). After hours, you may leave a message and your call will be returned the next business day.

Referring Physician Line

For adult and pediatric oncology call, 800.633.3853 (800.MED.DUKE)

Location

Durham, North Carolina

Facility

· Oncology inpatient units are housed together on one floor of Duke Hospital, with more than 100 beds dedicated solely to cancer care. There are specialized units for adult and pediatric bone marrow transplant.

· The Morris Cancer Clinics house the surgical and radiation oncology clinics, as well as the expanded North Carolina Jaycees Outpatient Treatment Facility. The medical oncology clinic is located in the Duke Clinic adjacent to the Morris Building.

· The outpatient and marrow processing facilities of the combined adult and pediatric Bone Marrow Transplantation Program are located on the first floor of North Pavilion, located two blocks from the hospital.

· A five-story, 65,000 square foot McGovern-Davison Children's Health Center (CHC) houses pediatric oncology activities.

· The administrative and basic research facilities of the Duke Cancer Institute occupy over half a million square feet of space throughout the Medical Center.

Travel Assistance

919.681.2020

Lodging

Many hotels and motels are within walking distance to Duke Hospital, or offer shuttle service. Some offer discounts to out-of-town family and friends. Call Patient and Visitor Relations at 919.681.2020 or 888.ASK.DUKE for more information.

The Host Homes Program provides accommodations for family members in local homes at minimal or no cost while the patient is undergoing treatment. Family members should provide their own transportation. Contact the Host Homes desk at 919.681.4688.

The Ronald McDonald House provides a home where families can stay while their children are receiving treatment at Duke Medical Center for serious illnesses. For further information on admission procedures call 919.286.9305 or go to www.ronaldhousedurham.org.

Caring House is available to adult out-of-town cancer outpatients. The facility provides comfortable, home-like accommodations; outpatients may bring a family member to stay with them. For more information, please call 919.490.5449 or go to www.caringhouse.org. For referrals to Caring House, contact an oncology social worker at 919.668.6676.

Treatment

Multidisciplinary Teams

Description

The Division of Medical Oncology and Transplantation

Provides diagnosis, evaluation, and treatment of all malignant disorders including solid tumors and hematologic malignancies. Stem Cell Transplantation from bone marrow and cord blood is used to treat leukemia, lymphoma, myeloma, solid tumors, and selected nonmalignant conditions. Division faculty participate in the research and development programs of the Duke Cancer Institute, the Center for Excellence in Molecular Hematology, the Bone Marrow Transplantation Program, the Cancer Prevention, Detection, and Control Program, the Cancer Genetics Network, the Drug Discovery and Experimental Therapeutics Program, and the Multidisciplinary Programs in Breast, Gastrointestinal and Thoracic Oncology, and Hematologic Malignancy.

The Breast Program

One of the most comprehensive treatment and research programs in the world, the program's mission is to deliver the most advanced, compassionate care to breast cancer patients and participate in basic and clinical investigations, leading to better ways to prevent, diagnose, and treat the disease. Duke's Breast Program allows women to be seen by a surgeon, medical oncologist, and radiation oncologist, all within one setting. The Duke Breast Program holds one of only 10 Specialized Programs of Research Excellence (SPORE) awards in breast cancer. These awards are presented by the National Cancer Institute for innovation and excellence in breast cancer research.

The Duke Thoracic Oncology Program

This program consists of nationally renowned physicians and scientists dedicated to advancing the care and outcomes of patients with non-small cell lung cancer, small cell lung cancer, mesothelioma, and other thoracic malignancies. For many lung cancer patients, the individualized care offered by the Duke program represents the best chance of survival and improved quality of life during and after treatment. Cancer care at Duke means having the benefit of specialists from every related medical field involved in planning your treatment, as well as support for you and your entire family.

The Brain Tumor Center

The Preston Robert Tisch Brain Tumor Center at Duke, established in 1937, was one of the first brain tumor research and clinical programs in the United States and is one of the leading pediatric and adult neuro-oncology programs in the world. Recognized by the National Institutes of Health as a leader in the research and treatment of brain tumors, the center is designated as the nation's first Specialized Research Center for Malignant Gliomas and Medulloblastomas from the National Institute of Neurological Disorders and Stroke. The Preston Robert Tisch Brain Tumor Center at Duke currently follows more than 2,000 patients with brain tumors from all over the world. With a 70-year history of achievement, The Brain Tumor Center at Duke continues to make major advances in curing brain and spinal tumors. Duke has one of only five Specialized Program of Research Excellence (SPORE) awards in brain cancer in the nation from the National Cancer Institute. The award recognizes researchers at Duke for their commitment to finding innovative ways to treat brain tumors.

Colon Cancer Treatment

Colon cancer treatment at Duke combines the expertise of world-class patient treatment teams with exciting advances in research for patients diagnosed with colorectal cancer. For many patients, the individualized care offered by Duke presents the best chances of survival and a better chance for a higher quality of life after treatment. Cancer care at Duke means you have the added benefit of specialists from every necessary medical field involved in planning your treatment program, as well as support for you and your entire family. Patients with colon cancer are treated in the Gastrointestinal Oncology Program, which combines the expertise of physicians and scientists from medical oncology, surgery, radiation oncology, pathology, epidemiology, and genetics. Duke offers the only intra-operative radiation facility of its kind in the Southeast, allowing the team to deliver a highly specialized form of radiation in the operating room. Intra-operative radiation therapy allows doctors to temporarily move sensitive organs from the radiation field so radiation can be delivered in high doses directly to the tumor.

Duke Gynecologic Oncology Program

The Duke Gynecologic Oncology Program is one of the most comprehensive cancer treatment, research, and training programs of its kind in the country. The program's mission is to deliver outstanding clinical care to women with gynecologic cancer and to participate in basic and clinical investigations that will improve prospects for early diagnosis, treatment, and prevention of these cancers.

The specific diseases treated by the Gynecologic Oncology Program are:

· Ovarian Cancer

· Cervical Cancer

· Uterine Cancer

· Vulvar Cancer

· Vaginal Cancer

· Fallopian Tube Cancer

The Gynecologic Oncology Program at Duke is consistently rated as one of the top 10 in the country by U.S. News & World Report. Duke was a major force in the formation of the Gynecologic Group, the main national cooperative clinical trials group for gynecologic cancers. To date, Duke has entered more patients in GOG trials than any other institution.

Prostate Clinic

The Duke Prostate Center (DPC) is one of the premier comprehensive cancer treatment, training, and research programs of its kind in the country. The program's mission is to deliver outstanding clinical care to men with prostate cancer and to participate in basic and clinical investigations that will improve prospects for early diagnosis, treatment, and prevention of this cancer. The Duke Prostate Center brings together scientists, urologic surgeons, medical oncologists, radiation oncologists, and other medical professionals to plan and carry out an individualized treatment plan for each patient. This multidisciplinary approach results in seamless clinical care, access to the latest therapies, faster translation of research discoveries into clinical practice, and increased patient satisfaction.

Melanoma Program

Duke's Melanoma Program is one of the most comprehensive melanoma treatment and research programs in the world. Duke cancer specialists are developing innovative technologies to detect melanoma at its earliest and most curable stage, while investigators are working in the laboratory to better understand the disease. Their research has led to exciting new therapies.

Bone Marrow/Stem Cell Transplantation

Duke has earned national and global recognition for its leadership in bone marrow and stem cell transplantation. The adult program is renowned for its pioneering efforts in the treatment of breast cancer with autologous bone marrow/stem cell transplantation and innovative approaches to the treatment of leukemia, lymphoma, and myeloma. Duke is also recognized for its extensive research into a variety of treatment modalities that can be combined with transplantation. These include immunotherapy, anti-angiogenesis therapy, and the latest chemotherapy and pharmacologic therapies.


Multidisciplinary Clinics

Disease Center

Contact Number

Breast Oncology

919.668.6688

Neuro-Oncology

919.684.5301

Gynecologic Oncology

919.684.3765

Thoracic Oncology

919.668.6688

Melanoma

919.684.8964

GI Oncology

919.668.6688

Lymphoma and Leukemia

919.681.7648

Esophageal

919.668.6688

Prostate Cancer

919.668.8108

Adult Bone Marrow and Stem Cell Transplant

919.668.1000

Head and Neck

919.668.6688

Bone and Soft Tissue

877.SARC.DUKE

Stem Cell Transplant Program

Duke has earned national and global recognition for its leadership in bone marrow/stem cell transplantation. The adult program is renowned for its pioneering efforts in the treatment of breast cancer with autologous bone marrow/stem cell transplantation and innovative approaches to the treatment of leukemia, lymphoma, and myeloma. Duke is also recognized for its extensive research into a variety of treatment modalities that can be combined with transplantation. These include immunotherapy, anti-angiogenesis therapy, and the latest chemotherapy and pharmacologic therapies.

Alternative/Complementary Medicine

Founded in 2000, Duke Integrative Medicine draws from the very best conventional and complementary/alternative medicine strategies to create a plan to help you optimize your health. We offer you the opportunity to immerse yourself deeply into this experience, and then we partner with you to implement the plan over time.

We believe that collectively, you and your health care providers should develop a health plan to address the whole person, because we believe there is a powerful interrelationship between the mind, body, spirit and community in both health and disease. All services are custom-designed to suit your individual needs and goals.

Integrative Oncology, a partnership between the Duke Cancer Institute and DCIM, provides a conduit to bring Integrative Medicine services to patients at Duke and is developing a robust research engine to practically evaluate various Integrative Medicine interventions offered to our patients-establishing benefit, minimizing harm, and generating evidence-based advice.

Long-Term Cancers Survivors Program

Long-term survivors of childhood and young adult cancer represent a special, growing population of individuals who have lived through, and conquered, a unique set of medical and psychosocial challenges. With greater than 70 percent of all children and young adults being cured of their primary tumors, Duke now has the opportunity and responsibility to study the long-term effects of treatment on these patients. While a great deal of effort continues to be expended to reduce the potential short-term and long-term toxicity of multi-modality cancer therapy without sacrificing efficacy, there is ample evidence to suggest that many current approaches will also continue to produce late effects. Moreover, since cancer treatment is a constantly evolving process, patients who received older and perhaps outdated therapies must continue to be evaluated. Finally, since the ability to cure most children and young adults with a wide variety of tumors is still in its infancy, it is not known, nor fully appreciated, what effects multi-agent chemotherapy and/or radiotherapy will have in an aging population of patients. For these many reasons, it is vitally important to establish combined multi-disciplinary clinical and research programs that have the capability to collect data retrospectively and prospectively on a large cohort of patients, analyze that data, and deliver medical care both reactively and perhaps preventively, based upon this information.

Cancer Prevention and Screening

Established in 1991, Duke's Cancer Prevention, Detection, and Control Research Program explores genetic and environmental factors that increase risk for cancer, and evaluates interventions to promote behaviors that can prevent cancer, lead to its early detection, and help patients cope with cancer treatment. Program goals are to develop, evaluate, and disseminate interventions to improve the early detection of cancer and promote behaviors that can prevent cancer and to identify genetic and environmental risk factors for cancer. Program activities include:

Support Services

The Duke Center for Survivorship encompasses the services of Duke's Cancer Patient Support Program, Duke's Oncology Recreation Therapy, and Duke's Cancer Education Program. Therapy, support, and education resources are offered to patients by professionally trained counselors and hundreds of volunteers.

The Center provides support groups and individual counseling as well as image enhancement services to cancer patients and their families. Music, games, crafts, and laughter are used to optimize functioning, coping, and quality of life during treatment. Through the center, popular hobbies such as genealogy research, painting, woodworking, tiling, flower arranging, and more are provided to survivors as both an emotional outlet and recreation. Multimedia information is provided to help survivors and their families understand their treatment options, make decisions, manage the effects of cancer and treatments, and find meaning in the experience. Books, audiotapes, videotapes, and online computer resources are available in the Patient and Family Resource Center.

Duke Cancer Patient and Family Support Programs

Duke Center for Cancer Survivorship

919.684.8571

Duke Cancer Patient Support Programs (Adult)

919.684.4497

Oncology Recreation Therapy Program

919.681.2928

Patient and Family Resource Center

919.613.6275

Oncology Social Work Program

919.668.6676

Brain Tumor Family Support Program

919.684.5301

Pediatric Blood & Marrow Transplant Family Support Program

919.668.1128

Support Groups:

* Breast Cancer Support Group

* Gynecologic & Breast Cancer Support Group

* Gastrointestinal & Pancreatic Cancer Support Group

* KidsCan! Support Group

* Leukemia, Lymphoma, and Multiple Myeloma Support Group

* Look Good...Feel Better® Program

* Lung Cancer Support Group

* Prostate Cancer Support Group

Nutrition Service

The Duke Health and Fitness Center, part of the Duke Center for Living, offers a program specifically to support cancer patients upon diagnosis, during, and after treatment. The C.A.R.E. program-Cancer and Regular Exercise-includes access to the Health and Fitness Center facilities and classes, an exercise program tailored to your goals and limitations, mind-body classes, and wellness lectures. Individualized nutritional counseling is also available. Call 919.660.6660 for more information or online at www.dukefitness.org.

Supportive Care

Pain Service and Palliative/Supportive Service

The Center for Palliative Care at Duke University Medical Center addresses the management of pain among patients from several perspectives.

Inpatient Pain Management

Duke University makes the control of our patients' pain a priority. Upon admission to Duke, most patient's pain is managed by the primary medical team. In the event a patient requires surgery, pain is initially managed by the patient's anesthesiologist and then by the patient's surgical team. Our anesthesiologists practice a multi-modal analgesia approach to pain which often begins with pre-emptive analgesia, that is, medications given prior to surgery in an attempt to prevent pain before it even starts. After surgery, many methods of pain control are available; these include IV medication (opioids) by patient controlled analgesia (PCA), regional anesthesia (nerve blocks or catheters) that provide local anesthetic to a specific limb or epidurals which deposit local anesthetic and opioids in the epidural space. As the patient begins to take sustenance by mouth, IV medications are typically transitioned to oral analgesia.

The Acute Pain Service (APS)

The Duke Acute Pain Service (APS), under the direction of Dr. Brian Ginsberg and with the assistance of four rotating attending anesthesiologists, provide 24/7 patient care coverage. Five full-time registered nurses (clinical nurse specialists), Duke Pain Medicine Fellows, senior anesthesia residents and medical students also participate in patient care.

The APS coordinates and manages pain in patients who elect to have analgesia administered via epidural or regional

anesthesia routes as well as in patients who present with complicated pain syndromes. The APS may be consulted by the primary medical providers when patients, adult or pediatric, are experiencing pain that is difficult for the primary team to manage. The APS utilizes a multimodal approach to pain management. The APS often works in conjunction with Physical Therapy and Stress Management experts to provide comprehensive care of our patients experiencing pain. The APS attendings are also intimately involved in pain management education hospital-wide.

Outpatient Pain Management

Outpatient Pain Management is based at the Duke Health Center Morreene Road Pain Clinic. This clinic is staffed with an interdisciplinary team that includes practitioners from Anesthesiology, Neurology, Neurosurgery, Psychology, Psychiatry, Nursing, and Physical Therapy. Patients undergo an extensive initial evaluation which results in an individualized, interdisciplinary treatment plan. A variety of pain management techniques are offered, including but not limited to complex medication regimens, single and multiple level nerve blocks; the evaluation, insertion, and management of epidural pumps and/or spinal cord stimulators; physical therapy techniques; and strategies including relaxation, biofeedback, and stress management. The Duke Morreene Road Pain Clinic evaluates and treats older adolescents and adults while pediatric patients are evaluated in a Pediatric Pain Clinic located in the Duke Children's Hospital.

Non-Pharmacological Management of Pain

Non-pharmacological management of pain is provided through several groups at Duke University Medical Center. The Stress Management Consult Team consists of one full-time and four part-time advanced practice registered nurses who work primarily with patients and their families during hospitalization. This team works with and educates

patients to manage their pain through relaxation techniques and complementary modalities. They also work with and educate various health care providers to help them provide better care and support to the patients. The Medical Psychology staff consists of psychologists who are available on a consultation basis and provide various non-pharmacological interventions such as biofeedback and relaxation exercises to both inpatients and clinic patients.

Home Care/Hospice Services

Duke HomeCare & Hospice is a community focused home care agency drawing on over 25 years of experience in providing quality home care to those in need. Duke HomeCare & Hospice provides innovative, thoughtful care, using an interdisciplinary team approach, to achieve the best possible outcomes for the patients, families, and communities. Their staff is on-call 24 hours a day, seven days a week to serve your needs.

Duke Home Infusion provides compassionate, quality home infusion care using a multidisciplinary approach and the most effective and efficient utilization of resources to achieve the best patient outcomes. Duke Home Infusion is JCAHO accredited.

Duke Home Health provides certified home health services for adult and pediatric patients needing nursing, rehabilitation (physical, occupational and/or speech language pathology therapies) and home health aides. When medically necessary, the services help patients adapt and recover from illness or injury in the comfort of their home.

Duke Hospice cares for patients who are seeking palliative end of life care. They provide care designed to manage symptoms and provide emotional and spiritual support. Care can be provided in the home, at an assisted living facility or in nursing homes. They also provide care in their six bed Inpatient Care Facility in Hillsborough, NC.

Duke Community Bereavement Services provides bereavement care to primary caregivers/family members of Hospice patients for up to 13 months following the death of a loved one. They also offer bereavement services to anyone in our community who has suffered a loss due to death or who requires critical incident debriefing..

Cooperative Group Membership

Cooperative Group Membership List

· CALGB

· GOG

· NSABP

· RTOG

· ACOS-OG

· COG

Activities in Cooperative Groups

Active participation in CALGB disease specific committees by faculty.

Average Number of Adult Clinical Trials

The Cancer Center has approximately 760 therapeutic and non-therapeutic clinical trials.

Clinical and Research Efforts

Duke is a member of the National Comprehensive Cancer Network (NCCN) and is the headquarters for the biostatistics group and data management group for The Cancer and Leukemia Group B (CALGB) and the overall headquarters for the American College of Surgeons Oncology Group (ACOSOG). At any one time, approximately 360 active protocols for new cancer treatments are open for patient enrollment at Duke. Over 1,000 patients are enrolled in cancer treatment research protocols, and another 1,500 to 3,000 individuals in companion and cancer control studies each year. Well-established teams of specialists in radiology, pathology, surgical, radiation, and medical oncology provide multidisciplinary care for individuals with breast cancer; lung cancer; and hematologic, gastrointestinal, and other malignancies.

No. of Inpatient Beds (Medical/Surgical)

No. of Discharges

Average Length of Stay

No. of Outpatient Encounters

No. of Oncologists (Medical and Surgical)

62 dedicated medical oncology
16 adult bone marrow transplant

More than 9,000 inpatient discharges per year

6.5 days

More than 238,000 per year

121